Assessing Medpace Hldgs: Insights From 9 Financial Analysts
Assessing Medpace Hldgs: Insights From 9 Financial Analysts
評估medpace控股：來自9位財務分析師的見解
A clear picture of Medpace...In the latest quarter, 9 analysts provided ratings for Medpace Hldgs (NASDAQ:MEDP), showcasing a mix of bullish and bearish perspectives.
在最新的季度中，有9位分析師爲Medpace Hldgs（納斯達克:MEDP）提供了評級，展示了一種看好和看淡的觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $402.67, a high estimate of $469.00, and a low estimate of $336.00. A decline of 7.99% from the prior average price target is evident in the current average.
分析師通過對12個月價格目標的評估提供更深入的見解，顯示出平均目標爲$402.67，高估爲$469.00，低估爲$336.00。從先前的平均價格目標下降了7.99%，當前平均價格目標可見。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
A clear picture of Medpace...
通過對最近...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間